Zepbound and Reproductive Health: What to Know About Pregnancy, Breastfeeding, and Birth Control
Tirzepatide, sold under the brand name Zepbound, is a weight-loss drug that works on two gut hormones at once…
-
-
Medicare Launches Temporary GLP-1 Bridge Program Amid New Evidence on Weight Loss Drugs in Older Adults
The Centers for Medicare and Medicaid Services just started a temporary program this week. This new project gives older…
-
Medicare Is Opening the Door Wider for Eli Lilly’s Weight Loss and Diabetes Drugs
Eli Lilly’s latest earnings report caught the attention of analysts and patients alike. The drugmaker reported $19.8 billion in…
-
CVS Caremark Reverses Course: Zepbound Reinstated, New Oral GLP-1 Added to Commercial Formularies
In a major shift, CVS Caremark, the nation’s largest pharmacy benefit manager (PBM) is reversing its controversial decision to…
-
Understanding Dose Strength Differences Between Foundayo and Zepbound
The federal approval of Foundayo on April 1, 2026, marks a major change in obesity care. This medication is…
-
New Weight-Loss Pill Foundayo vs Wegovy and Zepbound: What Sets It Apart
The Food and Drug Administration approved Foundayo on April 1, 2026. Reviewers used a special priority program to finish…
-
Lilly Wins FDA Nod for Zepbound Multi-Dose Pen, Boosting Convenience in Booming Weight-Loss Market
Eli Lilly and Company has won approval from the U.S. Food and Drug Administration for a new multi-dose version…
